BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29252171)

  • 1. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.
    Patsatsi A; Lamprou F; Kokolios M; Stylianidou D; Trigoni A; Kalampalikis D; Sotiriadis D
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):195-201. PubMed ID: 29252171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
    Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
    Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit.
    De D; Khullar G; Handa S; Saikia UN; Radotra BD; Saikia B; Minz RW
    Indian J Dermatol Venereol Leprol; 2016; 82(3):358. PubMed ID: 27088957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10 year period in Iran.
    Jowkar F; Sadati MS; Tavana S; Agah MA
    Acta Dermatovenerol Croat; 2014; 22(4):246-9. PubMed ID: 25580783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.
    Bernard P; Vaillant L; Labeille B; Bedane C; Arbeille B; Denoeux JP; Lorette G; Bonnetblanc JM; Prost C
    Arch Dermatol; 1995 Jan; 131(1):48-52. PubMed ID: 7826096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Autoimmune Blistering Disease: A Systematic Review.
    Zhao CY; Chiang YZ; Murrell DF
    Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
    Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
    Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Autoimmune Bullous Diseases in the Middle East: A 15-Year Review.
    Haber R; Helou J; Habr C; Tomb R
    Skinmed; 2017; 15(3):181-186. PubMed ID: 28705277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of autoimmune bullous diseases among children in Kuwait.
    Nanda A; Lazarevic V; Rajy JM; Almasry IM; AlSabah H; AlLafi A
    Pediatr Dermatol; 2021 Jan; 38(1):50-57. PubMed ID: 33043506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of six autoimmune bullous diseases with thyroid disorders: a population-based study.
    Kridin K; Hübner F; Linder R; Schmidt E
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1826-1830. PubMed ID: 35611551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study.
    Milinković MV; Janković S; Medenica L; Nikolić M; Reljić V; Popadić S; Janković J
    J Dtsch Dermatol Ges; 2016 Oct; 14(10):995-1005. PubMed ID: 27767273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review.
    Wong SN; Chua SH
    Br J Dermatol; 2002 Sep; 147(3):476-80. PubMed ID: 12207586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
    Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
    An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.
    Kridin K
    Immunol Res; 2018 Feb; 66(1):6-17. PubMed ID: 29159697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of autoimmune bullous diseases in Kuwait.
    Nanda A; Dvorak R; Al-Saeed K; Al-Sabah H; Alsaleh QA
    Int J Dermatol; 2004 Dec; 43(12):876-81. PubMed ID: 15569006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimizing therapy in patients with severe autoimmune blistering skin diseases].
    Schmidt E
    Hautarzt; 2009 Aug; 60(8):633-40. PubMed ID: 19536513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.